Title: Tomato TV– Bio-era heroes, a drug development dream team, are starting a new history.

Publication:  Tomato TV

Date: 10 June 2011

Summary

• CEO of LegoChem, Dr. Yong Zu Kim said "LegoChem is a venture company specializes in synthetic drug and for 4 and a half years after the foundation, it has secured many candidate substances for antibiotics, anticoagulants and oncology. Few of them are now in preclinical phase and few others have already gone through the preclinical phase. "            

• "Most of our employees have been working with each other for more than 10 to 20 years in a single area. We confidently say we have considerable competence and we will grow into a drug developing company that represents Korea.

To view the full article (in Korean), click here ▶

About LegoChem Biosciences

LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).